# Cohance Lifesciences Ltd (COHANCE)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹419.9
Day Change: -0.06%
52W High: ₹1121.15
52W Low: ₹266.7
Market Cap: ₹16,225 Cr

## Valuation
P/E: 90.15
P/B: 4.27
EPS: ₹4.7
Book Value: ₹99.19
Dividend Yield: 0%

## Returns
1Y Return: -38.08%

## Profitability
ROE: 0%
ROCE: 20.47%
Debt/Equity: 0.11
Revenue Growth: 77.3%
Profit Growth: -70.3%
EBITDA Margin: 14.81%
Operating Margin: 8.89%

## About
Cohance Lifesciences Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Cohance Lifesciences Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Concall Transcript: Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Access
Current tier: anonymous
More history: Register free to see 4 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:01.517Z
Price History Updated: 2026-05-18T22:58:20.087Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:20.087Z
Quant Updated: 2026-05-18T22:58:20.087Z
Sentiment Updated: 2026-05-18T22:58:20.087Z
Financials Status: current
Financials Updated: 2026-05-18T09:31:38.925Z
Financials Last Attempt: 2026-05-18T09:31:38.925Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2020)
Revenue: ₹378 Cr
Operating Profit: ₹172 Cr (OPM 45%)
Net Profit: ₹109 Cr
Tax: ₹158 Cr

## Annual P&L History
Mar 2020: Rev ₹378Cr | PAT ₹109Cr | OPM 45%
Mar 2021: Rev ₹834Cr | PAT ₹317Cr | OPM 46%
Mar 2022: Rev ₹1010Cr | PAT ₹362Cr | OPM 44%

## Balance Sheet (Mar 2020)
Total Assets: ₹783 Cr
Total Liabilities: ₹783 Cr
Borrowings: ₹83 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Umang  Vohra B.E., M.B.A., Executive Chairman
- Himanshu  Agarwal, Chief Financial Officer
- K.P Ravinatha Shetty, Platform Chief Operating Officer
- Cyndrella  Carvalho, Head of Investor Relations
- Sisir Kumar Mishra, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/cohance
Disclaimer: For research and education only. Not investment advice.